Milestone Pharmaceuticals
MIST
48 hedge funds and large institutions have $59M invested in Milestone Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 6 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
3.2% less ownership
Funds ownership: 65.22% → 62.01% (-3.2%)
4% less funds holding
Funds holding: 50 → 48 (-2)
31% less capital invested
Capital invested by funds: $85.5M → $59M (-$26.6M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $17K
Top Buyers
| 1 |
BlackRock
New York
|
+$2.18M |
| 2 |
AAA
Affinity Asset Advisors
New York
|
+$380K |
| 3 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$198K |
| 4 |
Squarepoint
New York
|
+$172K |
| 5 |
LPC
Lion Point Capital
New York
|
+$94.3K |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.93M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.28M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$578K |
| 4 |
JP Morgan Chase
New York
|
-$486K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$354K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Walleye Trading
New York
| – | -$49.3K | -12,513 | Closed |
|
|
OQS
52
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
| – | -$41.2K | -10,460 | Closed |
|
53
Group One Trading
Chicago,
Illinois
| – | -$953 | -242 | Closed |
|
|
MWM
54
Mascoma Wealth Management
Hanover,
New Hampshire
| – | -$363 | -100 | Closed |
|
MIST Hedge Fund Activity: Q2 2023 in Review
48 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Milestone Pharmaceuticals (MIST) for Q2 2023, worth a combined $59M — down 31% from $85.5M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of MIST and 4 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 20 added.
The largest buyer was BlackRock, adding an estimated $2.18M. The largest seller was Point72 Asset Management, cutting an estimated $3.93M.
- 48 institutional investors held Milestone Pharmaceuticals (MIST) as of Q2 2023, down from 50 in Q1 2023.
- Funds reported $59M of Milestone Pharmaceuticals stock for Q2 2023, down 31% quarter-over-quarter.
- 4 funds opened new Milestone Pharmaceuticals positions in Q2 2023 and 6 closed out, a net change of -2 holders.
- The largest Milestone Pharmaceuticals buyer in Q2 2023 was BlackRock, an estimated $2.18M added.
- The largest Milestone Pharmaceuticals seller in Q2 2023 was Point72 Asset Management, an estimated $3.93M sold.
Based on aggregated 13F filings for Q2 2023.